Diaceutics (LON:DXRX) Stock Price Up 0.8% - Still a Buy?

Diaceutics PLC (LON:DXRX - Get Free Report)'s share price was up 0.8% during mid-day trading on Friday . The company traded as high as GBX 120 ($1.65) and last traded at GBX 119.48 ($1.64). Approximately 72,885 shares changed hands during trading, a decline of 43% from the average daily volume of 127,715 shares. The stock had previously closed at GBX 118.50 ($1.63).

Diaceutics Trading Down 3.0%

The firm's fifty day simple moving average is GBX 125.12 and its 200 day simple moving average is GBX 128.94. The stock has a market capitalization of £96.21 million, a P/E ratio of -33.81 and a beta of 0.58. The company has a debt-to-equity ratio of 0.39, a quick ratio of 9.92 and a current ratio of 4.85.

Diaceutics (LON:DXRX - Get Free Report) last posted its quarterly earnings results on Tuesday, May 13th. The company reported GBX (2.02) (($0.03)) earnings per share (EPS) for the quarter. Diaceutics had a negative return on equity of 7.15% and a negative net margin of 10.90%. As a group, equities research analysts forecast that Diaceutics PLC will post 1.0107919 EPS for the current fiscal year.

Insider Activity

In related news, insider Peter Keeling sold 500,000 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of GBX 126 ($1.73), for a total transaction of £630,000 ($865,741.38). Company insiders own 34.30% of the company's stock.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.